ClinicalTrials.Veeva

Menu

Evaluation of Left Ventricular Function and Therapeutic Effect of CPAP in Patients With OSAS by 3D STE

P

Peking University

Status

Completed

Conditions

Left Ventricular Dysfunction
OSA

Treatments

Device: CPAP

Study type

Observational

Funder types

Other

Identifiers

NCT04957004
M2017397

Details and patient eligibility

About

The changes of left ventricular function in patients with sleep apnea were studied by three-dimensional speckle-tracking echocardiography to evaluate the changes of left ventricular function after CPAP treatment

Full description

Research purposes: (1) Use 3D speckle tracking echocardiography to measure the diastolic and systolic strains of the left atrium and left ventricle of OSAS patients, in order to evaluate the impact and degree of OSA on left ventricular function.

(2) By comparing the changes in the three-dimensional ultrasound strain index of the left ventricle of patients before and after CPAP treatment, and in patients receiving and not receiving CPAP treatment, to evaluate whether CPAP treatment contributes to the improvement of cardiac function in patients with OSAS, and to infer the best suitable intervention population and using time, providing reference basis for clinical treatment.

(3) Discovery of serological indicators that predict the severity of the disease and predict the impairment of heart function Study design: This study is a prospective, observational controlled study. It is planned to include 30 cases of newly diagnosed OSAS patients in the Peking University Third Hospital and a control group selected according to age and gender matching. The three-dimensional strain of the left atrium and left ventricle of the crowd is measured by the 3D speckle tracking technology, and the serological indicators are detected. The OSAS group and the control group were followed up during the course of receiving or not receiving CPAP.

Enrollment

60 patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. OSA met the diagnostic criteria of obstructive sleep apnea in the United States Classification of Sleep Diseases in 2014
  2. Between the ages of 18 and 80, regardless of gender
  3. Sign informed consent

Exclusion criteria

  1. previously diagnosed patients with heart failure,
  2. coronary artery disease,
  3. valvular disease,
  4. cardiomyopathy,
  5. arrhythmia,
  6. chronic obstructive/ restrictive pulmonary disease,
  7. thyroid dysfunction (including hypothyroidism or hyperthyroidism),
  8. already treated with CPAP,
  9. poor image quality of echocardiography.

Trial design

60 participants in 2 patient groups

OSA patients
Description:
Patients with OSA who have not been treated with CPAP
Treatment:
Device: CPAP
control group
Description:
health control except OSA by using sleep monitorin

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems